Delivery Order SPE2DB22D2206-SPE2DB25FJY79
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Briviact 50 mg tablets (60-count units) with a ceiling value of $3,639.16. This is a firm fixed-price delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion global pharmaceutical support vehicle valued through December 2026. The award was competitively granted with no set-aside designation...
- The Defense Logistics Agency awarded a delivery order valued at $7,488.40 to AmerisourceBergen Drug Corp for the supply of Briviact 50 mg tablets (60-count units) on June 18, 2025, with an ultimate completion date of June 20, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $1,861.34 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Briviact 25 mg tablets (60-count units). This is a firm fixed price, non-set-aside contract with a completion date of September 4, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $2,804.93 to AmerisourceBergen Drug Corp for 60 tablets of Briviact 50 mg on September 8, 2025, with completion targeted for September 9, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed price terms and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $8,509.97 delivery order to AmerisourceBergen Drug Corp for 60-count tablets of Briviact 100 mg, with an ultimate completion date of September 3, 2025. This is a firm fixed-price, non-set-aside contract performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global...
- The Defense Logistics Agency awarded a delivery order valued at $3,976.41 to AmerisourceBergen Drug Corp for the supply of Briviact 50 mg tablets (60-count units) on July 22, 2025, with completion scheduled for July 23, 2025. This firm fixed price delivery order represents a non-set-aside, competitively awarded contract with performance to be fulfilled at the contractor's Conshohocken, Pennsylvania location. The award is issued under AmerisourceBergen's existing Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $10,974.69 delivery order to AmerisourceBergen Drug Corp for Briviact 100 mg tablets (60-count units) under a firm fixed price contract. The award was made on August 1, 2025, with an ultimate completion date of August 4, 2025, and represents a non-competitive, non-set-aside procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same municipality. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Briviact 100 mg tablets (60-count) under a firm fixed-price contract with a ceiling value of $11,044.73. This non-set-aside competitive award is scheduled for completion by August 25, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $1,859.98 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Briviact 50 mg tablets (60-count packages). This firm fixed-price delivery order represents a non-set-aside, competitively awarded procurement supporting federal medical supply needs. The order is scheduled for completion by August 19, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $5,677.12 to AmerisourceBergen Drug Corp for the supply of Briviact 100 mg tablets (60-count units) on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitive, non-set-aside award employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026....
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJY79Delivery Order
The Defense Logistics Agency awarded a $5,576.04 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Briviact 50 mg tablets (60-count units). This is a non-set-aside competitive award with an ultimate completion date of September 18, 2025, and performance location in Conshohocken, Pennsylvania, where the contractor maintains its corporate office. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, leverages its prime IDC with the Defense Logistics Agency to fulfill critical medical supply needs for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The company's contract portfolio demonstrates extensive experience delivering a broad spectrum of pharmaceutical products across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and vaccines. This delivery order for Briviact, a psychiatric medication, exemplifies the routine pharmaceutical procurement executed through the DLA Troop Support Medical contract vehicle to support military and veteran healthcare requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 9/17/25 |